for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

shamoaner, talking crap again. Depending on the perceived price sensitivity of news, there is no requirement for any company to inform the market that a deal has been completed or otherwise.

Bosely.

Do my best for the video.

It's great to have a good debate regarding how high or how low the share price will go but some of the posters are taking themselves far too seriously. As mentioned by someone in an earlier post have the debate when there is something to talk about. At present we have we don't have any new "new" information to talk about.
Also some of the people taking themselves too seriously need to realise there are lots of us who have been in SEO since the dark days at 4p.

Where are the revenues going to come from? You really are in a world of your own!

So if a trial doesn't transcend into a deal the news is not price sensitive!

How on earth is an investor to know whether to invest or not if only positive news is released? Its not only illegal but also morally wrong to run a listed company in such a manner.

Best not to announce trials till they proceed to deals if your argument were to hold any water.

shamona
Just for you.

http://www.milinkito.com/swf/bart.php?texto=shamona+buy+SEO+you+know+it+makes+sense+150p+with+in+two+years&Submit=Crear+nueva+frase

shamoaner. if SEO were acting in an illegal manner the FSA would have taken action. This why you are not worth debating with, you talk complete crap with little knowledge of how the LSE actually works.

1548 million pound market at 1.50 driver, do you really believe thats gonna happen?

I don't!

Hi All,

Reiser and ABP didn't go forward because ASDA got in and they moved to the back burner, that's called priorities !

Isracaps are moving forward, they registered a domain name recently, and you don't do that unless you have plans to use it.

Bashers dig up any old tripe to try and get longs out, this long is still 100% in, and staying for 20+ (40,000%+ on the <5p I paid for my stock), in 3-5 years time.

Cheers,
PM

Meanwhile, back to more current happenings .... for those that missed all this info in amongst the dross .... here it is again ....

---------------------------------------------------------------------------

So far I have found four of the worlds top capsule manufacturers, and e-mailed them Stanelco's Capsules RNS.

I did tell them I was only a shareholder .... I guess that doesn't count as ramping .... LOL !

----------------------------------------------------
Pfizer own Capsugel, which had a turnover of $451m (up 5%) in H1 2005, they are the biggest in the world !

Coni-Snap capsules from CAPSUGEL are the world's most popular brand of two-piece gelatin capsule. The product of choice by leading pharmaceutical and dietary supplement companies for over 50 years, Coni-Snap capsules are renowned for their consistent and reliable performance"

http://www.capsugel.com/products/conisnap.php

http://www.pfizer.com/pfizer/are/mn_about_all.jsp

Other Pfizer Web Sites

Capsugel - The world's leading supplier of two-piece capsules.

----------------------------------------------------
Qualicaps Group is the industry leader in Japan taking more than 60 percent share in the pharmaceutical hard capsules market, and is the second largest in the global market including the U.S. and Europe. http://www.thecarlylegroup.com/eng/geo/news-3165.html

----------------------------------------------------
We are one of the largest manufacturers of hard gelatin capsules in the world http://www.acg-world.com/a.php

----------------------------------------------------
Overview
We are one of India's largest exporters of branded generic pharmaceuticals products. We
manufacture pharmaceuticals formulations in various dosage forms, including capsules, tablets,
liquid injectibles and we are one of the world's top five manufacturers of soft gel capsules. We
also have the only globally dedicated soft gel facility for hormones. In addition, we undertake
contract research and the manufacturing of speciality chemicals for various multinational
companies. We have a major presence in various developing countries such as Africa, Latin
America and Asia as well as in developed markets such as the US, Canada and parts of Europe.
We are one of the largest Indian suppliers of institutionally funded aid projects and we are an
approved supplier to the World Bank, the African Development Bank and UNICEF, amongst
others.
We have 11 manufacturing plants spread across the US, Brazil, Mexico and India. This
broad manufacturing network facilitates partnering with global organisations ranging from
UNICEF and WHO-Global Drug Facility to European and American pharmaceutical
multinationals and also private labellers and distribution chains. We have product registrations
in over 37 countries around the world and we have earned ISO 9001, ISO 14001 and GMP
accreditations. We employ approximately 1,300 people across the globe. We also have a
marketing presence in over 50 countries.
Our consolidated total revenues for fiscal 2002, 2003 and 2004 was Rs.2,781.49 million
(US$64.28 million), Rs.4,276.73 million (US$98.84 million) and Rs.4,624.50 million (US$106.88
million), respectively.


Overview
According to data from IMS Health Incorporated, or IMS, the world pharmaceutical market
size was estimated to be US$466 billion in 2003, based on audited retail sales of prescription
Pharmaceuticals and some over-the-counter products in more than 60 countries. IMS similarly
expects the global pharmaceutical market to show significant growth, despite continued
government pressure on pricing, measures for cost control and a number of widely-used drugs
going off patent, which usually results in a drop in price for those products. IMS estimates
average annual global sales to grow 18.5 per cent. and the global pharmaceutical market to
expand to US$561 billion by 2005. According to IMS, combined sales in the 13 leading markets
increased 8 per cent. to US$309.78 billion in 12 months up to November 2003. IMS predicts a
compound annual growth rate of 9.7 per cent. to US$688 billion for the global market over the
2002-2007 period. The United States market representing nearly half of all global sales is
expected to drive most of the world wide growth over this period with a CAGR of 12.5 per cent.
North America, the world's largest pharmaceutical market, accounted for US$172 billion of
pharmaceutical sales, or 54 per cent. of sales of the 13 key global markets. Over 70 per cent. of
the growth in the global pharmaceutical industry in 2003 came from the United States. For a
further description of the United States pharmaceutical industry, see "The United States
pharmaceutical market". http://www.stridesarco.com/

Chartists ....

Price is heading for a big bounce off the 200 M.A soon, make sure you don't miss it :)

Cheers,
PM

shamona Re "1.50 driver, do you really believe thats gonna happen"

Yes, could be more

pm1
You do like those capsules are you on any medication?

When, Driver - based on "average" deals resulting.....?

There was a once an old man could MAM and 12 months ago he called his 2 pretenders to him and gave them each 100,000 and told them to go forth into the world and seek better returns.

Now Bosley went out and found a company called SEO where he managed to buy 1,666,666 at 6p because he saw a future in their new products - and he shared his news with the world.

And Shamoaner - given the same opportunity went out into the world and invested in a company - also with a great potential future - and he bought 76,920 shares at 1.30.

Now at the end of a year, Mam called his pretenders to account:

Bosley was able t bestow upon his master a whopping 216,666 profit as his investment had reached an amazing 19p.

On the other hand Shamoaaner blamed all about him and tried to heap scorn and rumours of disaster on his rival as he brought home a thumping great loss of almost 77,000.

Now there must be a morale to this story somewhere which explains the sour grapes bestowed upon Shamoaner.

Of course - I never pay any attention to past history

Baza - can u tell I am bored !!

Driver Hi,

The industry loves those capsules, I had e-mails to that effect via my website .... LOL !

My medication starts later, and I wouldn't fancy vin rouge in a capsule, even if it was starch based :))))

Cheers,
PM

baz

http://www.milinkito.com/swf/bart.php?texto=BOS+%A3216%2C666+profit+Shamoaaner+%A377%2C000+DOWN+BOS+%A3216%2C666+profit+Shamoa&Submit=Crear+nueva+frase

markusantonius
I have always maintained 150p with in two years from April this year it could be more. The Earth wasnt built in seven days or some thing like that.

Masterson is posting details of other companies in the capsule business!!!!!!!!

QUOTE "The industry loves these capsules, I have emails to that affect posted to my website" Why don't you post said emails? Because they're a figment of your imagination perhaps!

Ramptastic masterson, you'll never change you sad man.

What possible help is that to any Stanelco investor??????

It onlty goes to show how much competition is already out there!

Note when difficult questions are asked he attempts to bury them with google responses, very sad that he can't be more forthright!

One notes no one attempts to correct his ramping though and 20 a share is given credence since it fits the longs agenda's, it also could be swallowed by the novices amongst you as facts. Ask Paul what happened to last years ramps, he conviently forgets his past mistakes.

My last post for now as I can see you all have rose tinted specs on.

http://www.milinkito.com/swf/bart.php?texto=PM1+up+from+5p+to+19p%2C+bprg+zombies+down+from+130p+to+30p+LOL+%21&Submit=Crear+nueva+frase

Jeez, guys - steady on with all this in-tribe squabbling. We all play for the same team, don't we? At this rate I'll be asking Queenie to come back!